Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study
Publication
, Journal Article
Walker, JL; Brady, MF; Wenzel, L; Fleming, GF; Huang, HQ; Disilvestro, PA; Fujiwara, K; Alberts, DS; Zheng, W; Tewari, KS; Cohn, DE; Van Le, L ...
Published in: Obstetrical and Gynecological Survey
August 1, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Obstetrical and Gynecological Survey
DOI
EISSN
1533-9866
ISSN
0029-7828
Publication Date
August 1, 2019
Volume
74
Issue
8
Start / End Page
474 / 476
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 4204 Midwifery
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Walker, J. L., Brady, M. F., Wenzel, L., Fleming, G. F., Huang, H. Q., Disilvestro, P. A., … Mannel, R. S. (2019). Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey, 74(8), 474–476. https://doi.org/10.1097/01.ogx.0000576976.42254.c2
Walker, J. L., M. F. Brady, L. Wenzel, G. F. Fleming, H. Q. Huang, P. A. Disilvestro, K. Fujiwara, et al. “Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study.” Obstetrical and Gynecological Survey 74, no. 8 (August 1, 2019): 474–76. https://doi.org/10.1097/01.ogx.0000576976.42254.c2.
Walker JL, Brady MF, Wenzel L, Fleming GF, Huang HQ, Disilvestro PA, et al. Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey. 2019 Aug 1;74(8):474–6.
Walker, J. L., et al. “Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study.” Obstetrical and Gynecological Survey, vol. 74, no. 8, Aug. 2019, pp. 474–76. Scopus, doi:10.1097/01.ogx.0000576976.42254.c2.
Walker JL, Brady MF, Wenzel L, Fleming GF, Huang HQ, Disilvestro PA, Fujiwara K, Alberts DS, Zheng W, Tewari KS, Cohn DE, Powell MA, Van Le L, Davidson SA, Gray HJ, Rose PG, Aghajanian C, Myers T, Secord AA, Rubin SC, Mannel RS. Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey. 2019 Aug 1;74(8):474–476.
Published In
Obstetrical and Gynecological Survey
DOI
EISSN
1533-9866
ISSN
0029-7828
Publication Date
August 1, 2019
Volume
74
Issue
8
Start / End Page
474 / 476
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 4204 Midwifery
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine